Perrigo Company Will Release First Quarter Fiscal Year 2013 Results on November 7, 2012
ALLEGAN, Mich., Oct. 23, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it will release financial results for its first quarter fiscal year 2013 on Wednesday, November 7th at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer.
The conference call will be available live via webcast to interested parties on the Perrigo website http://www.perrigo.com or by phone at 877-248-9413, International 973-582-2737, and reference ID# 46994711. A taped replay of the call will be available beginning at approximately 2:00 p.m. (ET) Wednesday, November 7, 2012 until midnight Friday, November 23, 2012. To listen to the replay, dial 855-859-2056, International 404-537-3406, and use access code 4699471.
From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).
SOURCE Perrigo Company
For further information: Arthur J. Shannon, Vice President, Investor Relations and Communication, +1-269-686-1709, email@example.com; Bradley Joseph, Senior Manager, Investor Relations and Communication, +1-269-686-3373, firstname.lastname@example.org